Exact Sciences' Q2 Loss Up 14 Percent; Reports Revenue from Genzyme Deal

Aug 12, 2009

NEW YORK (GenomeWeb News) – Exact Sciences today reported that its net loss for the quarter increased 14 percent on increased R&D spending and the recognition of revenues from its alliance with Genzyme announced earlier this year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Critics Say Open-Access Plan 'Goes Too Far'

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

Science and the Science Committee

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

And Gone

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

This Week in PLOS

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.

Featured White Papers

Potential Pitfalls to Life Science Product Launch

Freeze-drying - a manufacturing approach to increase the stability of in vitro diagnostic (IVD) assays

Contract Manufacturing in Biotech: Turning Your Supply Chain Into a Competitive Differentiator

The Foundry Model is Coming to Molecular Diagnostics, Courtesy of the Semiconductor Industry

Nov

29

Featured Webinar

Glass or Polymer? A Comparison for Use in In Vitro Diagnostic Biochips

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.

Dec

04

Featured Webinar

Clinical-Grade Exome Analysis for Complex and Unsolved Case Investigations

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec

11

Featured Webinar

Assessing the Impact of Different Aneuploid Findings with Independent NGS Platforms

This webinar describes a study that used two independent next-generation sequencing (NGS) platforms to gain insight into the impact of different types of aneuploidies during preimplantation genetic testing.

Dec

12

Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

Main menu